FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Panel to Discuss 2 Grass Allergy Tablets

[ Price : $8.95]

Federal Register Notice: FDAs Allergenic Products Advisory Committee will discuss Stallergenes Oralair and Mercks Grastek for gras...

Perrigo Recalls 18 Lots of Infant Liquid Acetaminophen

[ Price : $8.95]

Perrigo recalls 18 lots of its acetaminophen infant suspension liquid, 160 mg/5 mL, sold in 2 oz. and 4 oz. bottles with syringes.

Study Shows Opioid Drugs Increase Depression Risk

[ Price : $8.95]

A new study shows that opioid pain killers can increase the risk of developing major depression.

Mylan Sued Over ANDA for Generic Uloric

[ Price : $8.95]

Teijin Limited and Takeda Pharmaceuticals sue Mylan in connection with an ANDA submission for a generic copy of Uloric (febuxostat...

FDA Approves IGI Labs Site Transfer for Econazole Cream

[ Price : $8.95]

FDA approves an IGI Laboratories site transfer to move econazole nitrate cream 1% manufacturing to the companys facility in Buena,...

First Breakthrough Designated Drug OKd Genentechs Gazyva

[ Price : $8.95]

FDA approves the first breakthrough-designated drug a Genentech BLA for Gazyva (obinutuzumab) for use in combination with chloram...

Court Rules in Favor of Whistleblower Alleging FDA Non-Compliance

[ Price : $8.95]

The 11th Circuit Court of Appeals vacates a lower court decision that granted Bausch & Lomb summary judgment in a GMP non-complian...

Info on CMC Postapproval Changes Sent to OMB

[ Price : $8.95]

Federal Register Notice: FDA submits a proposed collection of information to the Office of Management and Budget on a guidance on ...

Nanotherapeutics Enrolls First Patient in Cervical Cancer Drug Trial

[ Price : $8.95]

Nanotherapeutics enrolls its first patient in a Phase 2 clinical trial of Triapine in combination with cisplatin and radiation in ...

Info on BLA General Licensing Sent to OMB

[ Price : $8.95]

Federal Register Notice: FDA submits a proposed collection on general licensing provisions for BLAs to the Office of Management an...